Mediprint Ophthalmics

An emerging San Diego-based clinical stage eye care pharmaceutical company developing and commercializing a proprietary ocular drug delivery portfolio focused on glaucoma, dry eye and ocular allergy initially. We are using our proprietary MediPrint process to develop, clinically test and commercialize drug-eluting, comfort-enhancing contact lenses to treat millions of patients worldwide, without the use of eye drops. We plan to address a variety of eye care unmet needs, all with extensive market opportunities. We aim to develop and commercialize a deep product pipeline, supported by strong intellectual property, with a highly experienced and successful execution team.